Work

Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials

Year: 2020

Type: article

Source: The Lancet Haematology

DOI: 10.1016/s2352-3026(19)30257-1

Authors: Frits van Rhee, Corey Casper, Peter M Voorhees, Luis E Fayad, Damilola Gibson, Karan Kanhai, Razelle Kurzrock

Institutions: University of Arkansas for Medical Sciences, Infectious Disease Research Institute, University of Washington, Levine Cancer Institute, The University of Texas MD Anderson Cancer Center, EUSA Pharma (United Kingdom), Moores Cancer Center

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Roche, EUSA Pharma, Janssen Pharmaceuticals

OpenAlex ID: W3003177605

FWCI: 3.177

Cites: 26

Cited by: 59

Related to: 10